Neoadjuvant Intralesional Daromun in Resectable Melanoma: Interpreting the PIVOTAL Trial
Journal of Cutaneous Oncology · 2026
DOI: 10.59449/joco.2026.09.25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Oncology, 2026. Verfasst von David Michael Miller und 7 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Miller, D. M., Buchbinder, E. I., Brownell, I., Khaddour, K., Khushalani, N. I., Cohen, J. V., Patel, V. A., & Wong, M. K. (2026). Neoadjuvant Intralesional Daromun in Resectable Melanoma: Interpreting the PIVOTAL Trial. Journal of Cutaneous Oncology. https://doi.org/10.59449/joco.2026.09.25
Vancouver
Miller DM, Buchbinder EI, Brownell I, Khaddour K, Khushalani NI, Cohen JV, et al. Neoadjuvant Intralesional Daromun in Resectable Melanoma: Interpreting the PIVOTAL Trial. Journal of Cutaneous Oncology. 2026. doi:10.59449/joco.2026.09.25
BibTeX
@article{Miller2026,
author = {Miller, David Michael and Buchbinder, Elizabeth I. and Brownell, Isaac and Khaddour, Karam and Khushalani, Nikhil I. and Cohen, Justine V. and Patel, Vishal Anil and Wong, Michael K.},
title = {Neoadjuvant Intralesional Daromun in Resectable Melanoma: Interpreting the PIVOTAL Trial},
journal = {Journal of Cutaneous Oncology},
year = {2026},
doi = {10.59449/joco.2026.09.25}
}
EUVIMED